Related Experiment Videos

Treatment outcome of Moraxella keratitis: our experience with 18 cases--a retrospective review

P Garg1, U Mathur, S Athmanathan

  • 1Sight Savers' Corneal Training Centre, L.V. Prasad Eye Institute, Hyderabad, India. prashant@lvpeye.stph.net

Cornea
|March 25, 1999
PubMed
Abstract

Insights

Moraxella keratitis, often linked to underlying health issues, can achieve favorable outcomes with appropriate medical treatment. Ciprofloxacin monotherapy is effective, especially given increasing cefazolin resistance in Moraxella strains.

Area of Science:

  • Ophthalmology
  • Infectious Diseases
  • Microbiology

Background:

  • Moraxella keratitis is an uncommon ocular infection.
  • Predisposing factors include systemic diseases and ocular surface abnormalities.

Purpose of the Study:

  • To analyze clinical presentation, risk factors, and treatment outcomes of Moraxella keratitis.
  • To evaluate in vitro antimicrobial susceptibility of Moraxella isolates.

Main Methods:

  • Retrospective review of 18 culture-proven cases of Moraxella keratitis.
  • Analysis of clinical data, predisposing factors, and treatment responses.

Main Results:

  • Associated conditions included Hansen's disease, diabetes, herpes zoster ophthalmicus, and malnutrition.
  • All isolates were susceptible to ciprofloxacin; 8/18 were resistant to cefazolin.
  • 14 eyes with follow-up data achieved favorable outcomes with medical treatment alone.

Conclusions:

  • Moraxella keratitis can have a favorable outcome, contrary to previous beliefs.
  • Cefazolin resistance is a concern, necessitating antimicrobial susceptibility monitoring.
  • Ciprofloxacin monotherapy is a viable treatment option due to cefazolin resistance.

Related Concept Videos